Suppr超能文献

JAK1的核输入由经典核定位信号介导,是弥漫性大B细胞淋巴瘤存活所必需的。

Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma.

作者信息

Zhu Fen, Hwang Byounghoon, Miyamoto Shigeki, Rui Lixin

机构信息

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.

出版信息

Mol Cancer Res. 2017 Mar;15(3):348-357. doi: 10.1158/1541-7786.MCR-16-0344. Epub 2016 Dec 28.

Abstract

JAKs are non-receptor tyrosine kinases that are generally found in association with cytokine receptors. In the canonical pathway, roles of JAKs have well been established in activating STATs in response to cytokine stimulation to modulate gene transcription. In contrast, a noncanonical role of JAK2 has recently been discovered, in which JAK2 in the nucleus imparts the epigenetic regulation of gene transcription through phosphorylation of tyrosine 41 on the histone protein H3. Recent work further demonstrated that this noncanonical mechanism is conserved with JAK1, which is activated by the autocrine cytokines IL6 and IL10 in activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL), a cancer type that is particularly difficult to treat and has poor prognosis. However, how JAK1 gains access to the nucleus to enable epigenetic regulation remains undefined. Here, we investigated this question and revealed that JAK1 has a classical nuclear localization signal toward the N-terminal region, which can be recognized by multiple importin α isoforms. Moreover, the nuclear import of JAK1 is independent of its kinase activity but is required for the optimal expansion of ABC DLBCL cells This study demonstrates that the nuclear import of JAK1 is essential for the optimal fitness of ABC DLBCL cells, and targeting JAK1 nuclear localization is a potential therapeutic strategy for ABC DLBCL. .

摘要

JAKs是非受体酪氨酸激酶,通常与细胞因子受体相关联。在经典途径中,JAKs在响应细胞因子刺激激活STATs以调节基因转录方面的作用已得到充分确立。相比之下,最近发现了JAK2的一种非经典作用,即细胞核中的JAK2通过组蛋白H3上酪氨酸41的磷酸化赋予基因转录的表观遗传调控。最近的研究进一步表明,这种非经典机制在JAK1中是保守的,JAK1在活化B细胞样弥漫性大B细胞淋巴瘤(ABC DLBCL)中被自分泌细胞因子IL6和IL10激活,ABC DLBCL是一种特别难以治疗且预后较差的癌症类型。然而,JAK1如何进入细胞核以实现表观遗传调控仍不清楚。在这里,我们研究了这个问题,并发现JAK1在其N端区域有一个经典的核定位信号,可被多种输入蛋白α异构体识别。此外,JAK1的核输入与其激酶活性无关,但对于ABC DLBCL细胞的最佳增殖是必需的。这项研究表明,JAK1的核输入对于ABC DLBCL细胞的最佳适应性至关重要,靶向JAK1核定位是ABC DLBCL的一种潜在治疗策略。

相似文献

1
Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma.
Mol Cancer Res. 2017 Mar;15(3):348-357. doi: 10.1158/1541-7786.MCR-16-0344. Epub 2016 Dec 28.
2
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7260-E7267. doi: 10.1073/pnas.1610970113. Epub 2016 Oct 31.
3
JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth.
Growth Factors. 2011 Dec;29(6):245-52. doi: 10.3109/08977194.2011.614949. Epub 2011 Sep 5.
4
Oncogenically active MYD88 mutations in human lymphoma.
Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.
5
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3975-3980. doi: 10.1073/pnas.1700682114. Epub 2017 Mar 29.
7
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
Br J Cancer. 2012 Jul 24;107(3):491-500. doi: 10.1038/bjc.2012.272. Epub 2012 Jun 21.
10
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638.

引用本文的文献

1
FERM domain-containing proteins are active components of the cell nucleus.
Life Sci Alliance. 2024 Jan 31;7(4). doi: 10.26508/lsa.202302489. Print 2024 Apr.
2
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy.
Cell Commun Signal. 2023 Oct 2;21(1):272. doi: 10.1186/s12964-023-01240-y.
3
The Seminiferous Epithelial Cycle of Spermatogenesis: Role of Non-receptor Tyrosine Kinases.
Adv Exp Med Biol. 2021;1288:1-20. doi: 10.1007/978-3-030-77779-1_1.
4
EGR1 Addiction in Diffuse Large B-cell Lymphoma.
Mol Cancer Res. 2021 Aug;19(8):1258-1269. doi: 10.1158/1541-7786.MCR-21-0267. Epub 2021 May 12.
5
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL).
Front Genet. 2021 Feb 10;12:625414. doi: 10.3389/fgene.2021.625414. eCollection 2021.
6
JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL).
Cancers (Basel). 2021 Jan 14;13(2):280. doi: 10.3390/cancers13020280.
7
Targeting nuclear import and export in hematological malignancies.
Leukemia. 2020 Nov;34(11):2875-2886. doi: 10.1038/s41375-020-0958-y. Epub 2020 Jul 5.
8
STAT3 Activation and Oncogenesis in Lymphoma.
Cancers (Basel). 2019 Dec 19;12(1):19. doi: 10.3390/cancers12010019.
9
Janus Kinase 1 Is Required for Transcriptional Reprograming of Murine Astrocytes in Response to Endoplasmic Reticulum Stress.
Front Cell Neurosci. 2019 Oct 11;13:446. doi: 10.3389/fncel.2019.00446. eCollection 2019.

本文引用的文献

1
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7260-E7267. doi: 10.1073/pnas.1610970113. Epub 2016 Oct 31.
5
IPO3-mediated Nonclassical Nuclear Import of NF-κB Essential Modulator (NEMO) Drives DNA Damage-dependent NF-κB Activation.
J Biol Chem. 2015 Jul 17;290(29):17967-17984. doi: 10.1074/jbc.M115.645960. Epub 2015 Jun 9.
6
Targeting JAK kinase in solid tumors: emerging opportunities and challenges.
Oncogene. 2016 Feb 25;35(8):939-51. doi: 10.1038/onc.2015.150. Epub 2015 May 18.
7
The JAK-STAT pathway: impact on human disease and therapeutic intervention.
Annu Rev Med. 2015;66:311-28. doi: 10.1146/annurev-med-051113-024537.
8
Mechanism of activation of protein kinase JAK2 by the growth hormone receptor.
Science. 2014 May 16;344(6185):1249783. doi: 10.1126/science.1249783.
9
Targeting the β-catenin nuclear transport pathway in cancer.
Semin Cancer Biol. 2014 Aug;27:20-9. doi: 10.1016/j.semcancer.2014.04.012. Epub 2014 May 9.
10
JAKs and STATs in immunity, immunodeficiency, and cancer.
N Engl J Med. 2013 Jan 10;368(2):161-70. doi: 10.1056/NEJMra1202117.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验